LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) Disease remission reported as DORIS response seen in 2 out of 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback